We describe a strategy for fabricating chitin and dibutyrylchitin –an organo-soluble chitin derivative- nanoparticles (NPs) encapsulating a model antigen (ovalbumin) or iron oxide nanocrystals. The use of MRI enabled the determination of the cell migration of vaccinated cells, allowing the determination of the immunization efficiency in early stages. To form DBC, a reversible acylation of chitin was performed and NPs were fabricated using an emulsification/evaporation method, then chitin was regenerated by alkaline saponification. NPs had vaccine adjuvant properties and allowed the track of immune cells to lymph nodes, proving their utility as vaccine adjuvants and imaging agents.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords